🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
1.810
-0.050 (-2.69%)
At close: Nov 20, 2026, 4:00 PM EST
1.840
+0.030 (1.66%)
After-hours: Nov 20, 2026, 5:33 PM EST

BBOT Statistics

Total Valuation

BBOT has a market cap or net worth of $145.25 million. The enterprise value is -$167.70 million.

Market Cap145.25M
Enterprise Value -167.70M

Important Dates

The last earnings date was Tuesday, November 10, 2026, after market close.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

BBOT has 80.25 million shares outstanding. The number of shares has increased by 628.00% in one year.

Current Share Class 80.25M
Shares Outstanding 80.25M
Shares Change (YoY) +628.00%
Shares Change (QoQ) +0.16%
Owned by Insiders (%) 0.02%
Owned by Institutions (%) 49.63%
Float 40.77M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.49
P/TBV Ratio 0.50
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.01.

Current Ratio 4.08
Quick Ratio 3.80
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -46.35% and return on invested capital (ROIC) is -31.40%.

Return on Equity (ROE) -46.35%
Return on Assets (ROA) -28.17%
Return on Invested Capital (ROIC) -31.40%
Return on Capital Employed (ROCE) -63.44%
Weighted Average Cost of Capital (WACC) 8.81%
Revenue Per Employee n/a
Profits Per Employee -$2.04M
Employee Count84
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -85.73% in the last 52 weeks. The beta is 0.86, so BBOT's price volatility has been lower than the market average.

Beta (5Y) 0.86
52-Week Price Change -85.73%
50-Day Moving Average 3.14
200-Day Moving Average 7.40
Relative Strength Index (RSI) 28.93
Average Volume (20 Days) 657,617

Short Selling Information

The latest short interest is 3.47 million, so 4.32% of the outstanding shares have been sold short.

Short Interest 3.47M
Short Previous Month 3.85M
Short % of Shares Out 4.32%
Short % of Float 8.51%
Short Ratio (days to cover) 5.57

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -187.26M
Pretax Income -171.53M
Net Income -171.53M
EBITDA -186.95M
EBIT -187.26M
Earnings Per Share (EPS) -$2.14
Full Income Statement

Balance Sheet

The company has $315.33 million in cash and investments and $2.38 million in debt, with a net cash position of $312.95 million or $3.90 per share.

Cash & Investments 315.33M
Total Debt 2.38M
Net Cash 312.95M
Net Cash Per Share $3.90
Equity (Book Value) 293.39M
Book Value Per Share 3.66
Working Capital 157.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$150.88 million and capital expenditures -$157,000, giving a free cash flow of -$151.03 million.

Operating Cash Flow -150.88M
Capital Expenditures -157,000
Depreciation & Amortization 310,000
Net Borrowing n/a
Free Cash Flow -151.03M
FCF Per Share -$1.88
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BBOT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -628.00%
Shareholder Yield -628.00%
Earnings Yield -118.15%
FCF Yield -103.98%

Analyst Forecast

The average price target for BBOT is $20.91, which is 1,055.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.91
Price Target Difference 1,055.25%
Analyst Consensus Strong Buy
Analyst Count 12
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1